{
    "id": 26189,
    "fullName": "BTK C481R",
    "impact": "missense",
    "proteinEffect": "loss of function",
    "geneVariantDescriptions": [
        {
            "description": "BTK C481R lies within the protein kinase domain of the Btk protein (UniProt.org). C481R confers a loss of function to the Btk protein as indicated by reduced enzymatic activity in vitro compared to wild-type Btk (PMID: 27571029, PMID: 27282255).",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 8364,
                    "pubMedId": 27571029,
                    "title": "Battling Btk Mutants With Noncovalent Inhibitors That Overcome Cys481 and Thr474 Mutations.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27571029"
                },
                {
                    "id": 7678,
                    "pubMedId": 27282255,
                    "title": "Substitution scanning identifies a novel, catalytically active ibrutinib-resistant BTK cysteine 481 to threonine (C481T) variant.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27282255"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 695,
        "geneSymbol": "BTK",
        "terms": [
            "BTK",
            "AGMX1",
            "AT",
            "ATK",
            "BPK",
            "IGHD3",
            "IMD1",
            "PSCTK1",
            "XLA"
        ]
    },
    "variant": "C481R",
    "createDate": "03/28/2017",
    "updateDate": "06/24/2018",
    "referenceTranscriptCoordinates": {
        "id": 143933,
        "transcript": "NM_000061",
        "gDna": "chrX:g.101356177A>G",
        "cDna": "c.1441T>C",
        "protein": "p.C481R",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 11550,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, a patient with Waldenstr\u00f6m macroglobulinemia, a form of non-Hodgkin lymphoma, harboring BTK C481R, BTK C481S, CXCR4 mutant, and MYD88 L265P, demonstrated resistance to treatment with Imbruvica (ibrutinib) (PMID: 28235842).",
            "molecularProfile": {
                "id": 28134,
                "profileName": "BTK C481R BTK C481S CXCR4 mut MYD88 L265P"
            },
            "therapy": {
                "id": 768,
                "therapyName": "Ibrutinib",
                "synonyms": null
            },
            "indication": {
                "id": 60060,
                "name": "non-Hodgkin lymphoma",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 9635,
                    "pubMedId": 28235842,
                    "title": "Acquired mutations associated with ibrutinib resistance in Waldenstr\u00f6m macroglobulinemia.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28235842"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 11551,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, a patient with Waldenstr\u00f6m macroglobulinemia, a form of non-Hodgkin lymphoma, harboring BTK C481R, BTK C481S, CARD11 L878F, and MYD88 L265P, demonstrated resistance to treatment with Imbruvica (ibrutinib) (PMID: 28235842).",
            "molecularProfile": {
                "id": 28138,
                "profileName": "BTK C481R BTK C481S CARD11 L878F MYD88 L265P"
            },
            "therapy": {
                "id": 768,
                "therapyName": "Ibrutinib",
                "synonyms": null
            },
            "indication": {
                "id": 60060,
                "name": "non-Hodgkin lymphoma",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 9635,
                    "pubMedId": 28235842,
                    "title": "Acquired mutations associated with ibrutinib resistance in Waldenstr\u00f6m macroglobulinemia.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28235842"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 27379,
            "profileName": "BTK C481R",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 28134,
            "profileName": "BTK C481R BTK C481S CXCR4 mut MYD88 L265P",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 28138,
            "profileName": "BTK C481R BTK C481S CARD11 L878F MYD88 L265P",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 143933,
            "transcript": "NM_000061",
            "gDna": "chrX:g.101356177A>G",
            "cDna": "c.1441T>C",
            "protein": "p.C481R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}